Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Abbisko Therapeutics Announces Worldwide Collaboration with Lilly to Discover and Develop Novel Molecules
Abbisko Therapeutics Co., Ltd. (“Abbisko Therapeutics” hereafter), a subsidiary of Abbisko Cayman Limited (Stock Code: […]
Ryvu Therapeutics Appoints Hendrik Nogai, M.D. as Chief Medical Officer
Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule […]
MicroPort CRM Receives Approval in Japan for Alizea Bluetooth Pacemaker
MicroPort CRM, a pioneering company in the field of Cardiac Rhythm Management, headquartered in France, recently […]
NHS Launches Landmark Mental Health Campaign With ‘Help!’ From The Beatles
Today, the NHS will launch a new landmark campaign using the iconic Beatles song ‘Help!” […]
Cheshire-based Life Sciences Startup Cryoniss Secures £500,000 Investment From NPIF Maven Equity Finance
NPIF Maven Equity Finance, managed by Maven Capital Partners (“Maven”) and part of the Northern […]
Digital Health Leader Verana Health Secures $150M Series E Funding Round
Verana Health, a digital health company that delivers quality drug lifecycle and medical practice insights […]
LumiraDx Lab Analysis Confirms its COVID-19 Antigen Test Detects the Omicron Variant
LumiraDx (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced that results from ongoing […]
New Study: Decentralized Clinical Trials Can Achieve Net Financial Benefits of 5X to 14X, Due to Reduced Trial Timelines and Other Factors
Medable Inc., the leading cloud platform for patient-centered drug development, today announced results from a […]
Aristea Therapeutics Announces Key Leadership Appointments to Advance its Clinical Pipeline
Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company advancing novel therapies to treat […]
BICO Partners with the Center for Contemporary Sciences (CCS) to Reduce Animal Testing in Life Sciences
Today BICO, a leading bio convergence company, announced a partnership with the Center for Contemporary […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more